Founded
Address
Venrock Associates
55 Cambridge Parkway
Suite 100
Cambridge, MA 02142
United States
Venrock Associates
Palo Alto, CA 00000
United States
Phone
Website
Recent investment activity
KANDO id: 32106
Corporate information
Registration country
Company type
The venture capital arm of the Rockefeller Family.Funding rounds
Investment preferences
Minimum investment (USD)
2,000,000
Maximum initial investment (USD)
40,000,000
Investment size comment
USD 10 million sweet spot.
Stage focus
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 283| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Cerulean Pharma Inc | Series C Initial investment | ||||
|
|
SocialShield | Series A Initial investment | ||||
|
Quantenna Communications Inc | Wireless semiconductors. | Series E Follow-on investment | |||
|
|
Red Beacon Inc | Series A Initial investment | ||||
|
|
Castlight Health Inc | Series C | ||||
|
Constellation Pharmaceuticals Inc | Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics | Series B Follow-on investment | |||
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series E Follow-on investment | |||
|
|
Teranetics Inc | A fabless semiconductor company that is developing silicon solutions for 10 Gigabit Ethernet over copper. | N/A Follow-on investment | |||
|
|
Smartling Inc | Series A Initial investment | ||||
|
|
Quantenna Communications Inc | Wireless semiconductors. | Series D Follow-on investment | |||
|
Billfloat Inc | Offers consumers “more time to pay” their bills on time to help avoid late fees, overdraft charges, service termination and high cost loans. | Seed | |||
|
|
Intuity Medical Inc | Series D Initial investment | ||||
|
|
Mevion Medical Systems Inc | Radiation therapy company dedicated to advancing the treatment of cancer. | N/A Initial investment | |||
|
|
Neurocrine Biosciences Inc | Therapeutics for diseases and disorders of the central nervous and immune systems. | N/A Initial investment | |||
|
Cloudflare Inc | Web performance and security company. | Series A | |||
|
Fate Therapeutics Inc | Series B Follow-on investment | ||||
|
|
Receptos Inc [] | Series A Initial investment | ||||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | N/A Follow-on investment | |||
|
|
Canesta Inc | Provider of electronic perception technology in the United States. | Series E | |||
|
|
Cerulean Pharma Inc | Series B Follow-on investment | ||||
|
|
Quantenna Communications Inc | Wireless semiconductors. | Series C Initial investment | |||
|
|
Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | N/A Initial investment | |||
|
Anacor Pharmaceuticals Inc | Series E Initial investment | ||||
|
Boston-Power Inc | Series D | ||||
|
|
World Heart Corp | Medical device company developing implantable mechanical circulatory support systems for long-term use. | N/A Initial investment |